Devon Christie, MD, is the Medical and Therapeutic Services Director with Numinus Wellness Inc., a Canadian-based company at the forefront of advancing ...
Hematology and Oncology at Jazz Pharmaceuticals, discusses the "Nothing Small About It" online program developed with leading cancer organizations focus...
Jared Silver, MD, PhD, Allergist Immunologist & Indication Lead for Mepolizumab, US Medical Affairs Respiratory at GSK discusses the recent FDA approval...
Lisa Anderson, CEO, President and co-founder of Paragonix Technologies, Inc., a company delivering a new standard in organ preservation and transport, d...
Shannon Resetich, Global Franchise Head, Rare Diseases at Sanofi Genzyme discusses the company's Humanitarian Aid Program started 30 years ago.
Alan Rechter, MD, an orthopedic surgeon, from Orthopoedic Associates in Houston, TX, discusses the newest method of effectively managing postoperative p...
Carla Mack, Global Head of Professional Affairs at Alcon discusses the company's latest innovation, TOTAL30®, the first-and-only monthly replacement, w...
August is Spinal Muscular Atrophy (SMA) Awareness Month, and this year (2021) also marks the first anniversary of the FDA approval of Evrysdi (risdiplan...
Michael Frank, CEO and Chairman of Revive Therapeutics discusses the Phase 3 trial of Bucillamine, a well known prescribed anti-inflammatory drug in Jap...
Erik Rifkin, PhD, co-founders of the Center for Interpreting Health Benefits and Risk discuss their new book "Understanding COVID-19 Risks: An Image is ...